Skip to content
HowShorted

FILANA THERAPEUTICS, INC. short interest in 2025

In 2025, FILANA THERAPEUTICS, INC.'s disclosed short interest ran from 31.93% of shares outstanding on 15 Jan 2025 to 14.94% on 31 Dec 2025, a change of -16.99 percentage points. The year's high was 33.14% on 14 Feb 2025 and its low 12.19% on 15 Sep 2025, averaging 19.08% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.88 days on 14 Feb 2025. Full history: FILANA THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for FILANA THERAPEUTICS, INC. in 2025

2025 in figures

Start of year
31.93% (15 Jan 2025)
End of year
14.94% (31 Dec 2025)
Change
-16.99 pp
High
33.14% (14 Feb 2025)
Low
12.19% (15 Sep 2025)
Average
19.08%
Highest days to cover
13.88 (14 Feb 2025)
SEC filings marked
9

Every report in 2025

FILANA THERAPEUTICS, INC. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202531.93%4.20results (8-K)
31 Jan 202532.95%11.49
14 Feb 202533.14%13.88
28 Feb 202529.90%8.13
14 Mar 202524.59%7.6110-K filed, results (8-K)
31 Mar 202523.08%3.73
15 Apr 202522.97%9.05
30 Apr 202520.77%11.96
15 May 202520.77%11.4110-Q filed, results (8-K)
30 May 202518.28%5.55
13 Jun 202517.02%10.23
30 Jun 202514.50%5.28
15 Jul 202513.00%7.69
31 Jul 202513.09%7.16
15 Aug 202512.92%7.3610-Q filed, results (8-K)
29 Aug 202512.69%11.09
15 Sep 202512.19%12.29
30 Sep 202515.38%1.00
15 Oct 202514.17%1.97
31 Oct 202515.29%3.69
14 Nov 202515.14%7.7810-Q filed, results (8-K)
28 Nov 202514.97%5.64
15 Dec 202514.19%9.01
31 Dec 202514.94%5.77

See also: FILANA THERAPEUTICS, INC.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.